Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers
-
Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma
-
Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer
-
Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer
-
Trixeo Aerosphere approved in the EU for maintenance treatment of COPD
-
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
-
Enhertu continues to demonstrate durable responses with new data from DESTINY-Breast01 in HER2-positive metastatic breast cancer
-
AZD1222 Oxford Phase III trials interim analysis results published in The Lancet
Latest articles and press releases
All of our latest press releases and articles are available to explore
